Literature DB >> 11991597

Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C.

Junichi Tazawa1, Manabu Maeda, Mina Nakagawa, Hideo Ohbayashi, Fumihiko Kusano, Michio Yamane, Yoshinori Sakai, Keiko Suzuki.   

Abstract

It is unknown whether diabetes mellitus is a risk factor of the hepatocarcinogenesis in patients with chronic hepatitis C. Three hundred eleven anti-hepatitis C virus (HCV) -positive patients who had undergone liver biopsies were studied. Patients with histologically proven cirrhosis or withdrawing within 12 months were excluded. Thus, the remaining 279 patients were followed-up for 65.9 +/- 29.4 months until the occurrence of hepatocellular carcinoma (HCC). During the observation period, HCC developed in 13 patients. Diabetes, age, sex, habitual alcohol intake, history of blood transfusion, serum alpha-fetoprotein level, histological findings, HCV genotype, viral load, and interferon therapy were assessed as potential risk factors. The Cox proportional hazard model identified that diabetes mellitus, histological staging, and age were independently associated with the occurrence of HCC. With multivariate analysis, only diabetes mellitus and age were associated with the occurrence of HCC. Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C.

Entities:  

Mesh:

Year:  2002        PMID: 11991597     DOI: 10.1023/a:1014715327729

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

1.  Attributable risks for hepatocellular carcinoma in northern Italy.

Authors:  C Braga; C La Vecchia; E Negri; S Franceschi
Journal:  Eur J Cancer       Date:  1997-04       Impact factor: 9.162

Review 2.  Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma.

Authors:  M Colombo
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

3.  Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection.

Authors:  S Caronia; K Taylor; L Pagliaro; C Carr; U Palazzo; J Petrik; S O'Rahilly; S Shore; B D Tom; G J Alexander
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

4.  Risk factors for hepatocellular carcinoma among patients with chronic liver disease.

Authors:  H Tsukuma; T Hiyama; S Tanaka; M Nakao; T Yabuuchi; T Kitamura; K Nakanishi; I Fujimoto; A Inoue; H Yamazaki
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

5.  A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis.

Authors:  K Ikeda; S Saitoh; I Koida; Y Arase; A Tsubota; K Chayama; H Kumada; M Kawanishi
Journal:  Hepatology       Date:  1993-07       Impact factor: 17.425

6.  Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population.

Authors:  M E Allison; T Wreghitt; C R Palmer; G J Alexander
Journal:  J Hepatol       Date:  1994-12       Impact factor: 25.083

7.  Risk factors and predictors of outcome in an Australian cohort with hepatitis C virus infection.

Authors:  S I Strasser; K J Watson; C S Lee; P J Coghlan; P V Desmond
Journal:  Med J Aust       Date:  1995-04-03       Impact factor: 7.738

8.  Hepatocellular carcinoma in Italian patients with cirrhosis.

Authors:  M Colombo; R de Franchis; E Del Ninno; A Sangiovanni; C De Fazio; M Tommasini; M F Donato; A Piva; V Di Carlo; N Dioguardi
Journal:  N Engl J Med       Date:  1991-09-05       Impact factor: 91.245

9.  Degree of diversity of hepatitis C virus quasispecies and progression of liver disease.

Authors:  M Honda; S Kaneko; A Sakai; M Unoura; S Murakami; K Kobayashi
Journal:  Hepatology       Date:  1994-11       Impact factor: 17.425

10.  A case-control study of diabetes mellitus and cancer risk.

Authors:  C La Vecchia; E Negri; S Franceschi; B D'Avanzo; P Boyle
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

View more
  20 in total

Review 1.  Hepatitis C virus infection and insulin resistance.

Authors:  Sandip K Bose; Ranjit Ray
Journal:  World J Diabetes       Date:  2014-02-15

Review 2.  Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Dilia Giuggioli; Andrea Di Domenicantonio; Ilaria Ruffilli; Alda Corrado; Silvia Fabiani; Santino Marchi; Clodoveo Ferri; Ele Ferrannini; Poupak Fallahi
Journal:  World J Diabetes       Date:  2014-10-15

3.  Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma.

Authors:  Valter Donadon; Massimiliano Balbi; Francesca Valent; Angelo Avogaro
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

4.  Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression.

Authors:  Arup Banerjee; Keith Meyer; Budhaditya Mazumdar; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

Review 5.  Chronic hepatitis C virus infection and post-liver transplantation diabetes mellitus.

Authors:  Yun Ma; Wen-Wei Yan
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

6.  Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1.

Authors:  Teruko Hino-Arinaga; Tatsuya Ide; Ryoko Kuromatsu; Ichiro Miyajima; Kei Ogata; Reiichiro Kuwahara; Akiko Hisamochi; Takuji Torimura; Michio Sata
Journal:  J Gastroenterol       Date:  2011-12-21       Impact factor: 7.527

7.  Diabetes mellitus impairs the response to intra-arterial chemotherapy in hepatocellular carcinoma.

Authors:  Yin-Hsun Feng; Cheng-Yao Lin; Wen-Tsung Huang; Chia-Ling Wu; Jui-Lung Fang; Chao-Jung Tsao
Journal:  Med Oncol       Date:  2010-08-24       Impact factor: 3.064

Review 8.  Hepatitis C virus induced insulin resistance impairs response to anti viral therapy.

Authors:  Abdel-Rahman El-Zayadi; Mahmoud Anis
Journal:  World J Gastroenterol       Date:  2012-01-21       Impact factor: 5.742

9.  Alcohol, postprandial plasma glucose, and prognosis of hepatocellular carcinoma.

Authors:  Hiroshi Abe; Yuta Aida; Haruya Ishiguro; Kai Yoshizawa; Tamihiro Miyazaki; Munenori Itagaki; Satoshi Sutoh; Yoshio Aizawa
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

Review 10.  Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.

Authors:  Diego Garcia-Compean; Joel Omar Jaquez-Quintana; Jose Alberto Gonzalez-Gonzalez; Hector Maldonado-Garza
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.